Open-Label Study (ARIDO) Evaluating Long-Term Safety of Topical Glycopyrronium Tosylate (GT) in Patients With Primary Axillary Hyperhydrosis. J of Skin 2018, 2 (S1), S40. https://doi.org/10.25251/skin.2.supp.40.